R A Inc logo — company profile

R A Inc

Founded 2008 United States Boston, United States 1 employees Post-IPO Equity Total: $226.93M Biotechnology, Pharmaceutical

General Information

Company Name R A Inc
Founded Year 2008
Location United States Boston, United States
Employees 1
Industries Biotechnology, Pharmaceutical
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with R A Inc. To contact R A Inc, visit rapharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does R A Inc compare?

A PDF of R A Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting R A Inc soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About R A Inc

Ra Pharmaceuticals is a biotechnology and pharmaceutical company that was founded in 2008 in the United States. The company's focus is on delivering the untapped potential of peptides. They recently received a significant $149.50M Post-IPO Equity investment on 29 July 2019. This infusion of capital demonstrates notable confidence in the company and its potential for growth and innovation within the biotech and pharmaceutical industries.

Business keywords: peptides, Cyclomimetics, drug development, antibodies, small molecules, drug candidates, intracellular protein-protein interactions, unmet medical needs, life sciences, pharmaceuticals, innovation, partnering, headquarters

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $149.50M -
29 Jul 2019
Series B $58.50M 9
New Enterprise Associates, Amgen Ventures +7
23 Jul 2015
Series A $8.60M -
16 May 2012
Venture Round $10.33M -
25 Feb 2010

R A Inc Alternatives & Competitors

View All Alternatives
R A Inc vs

DEVELOPING INNOVATIVE TREATMENTS FOR GENITOURINARY TRACT DISORDERS

Venture round
2 employees
Biopharma, Biotechnology
R A Inc vs
FogPharma
FogPharma United States

Until everything is druggable.

Series E
146 employees
Biopharma, Biotechnology
R A Inc vs

We're a growth-oriented biopharmaceutical company improving patient lives by developing and commerci...

Post-IPO Debt
396 employees
Biotechnology, Health Care

FAQ About R A Inc

Ra Pharmaceuticals, Delivering on the untapped potential of peptides.
R A Inc was founded in 2008.
R A Inc is headquartered in Boston, United States.
R A Inc operates in Biotechnology and Pharmaceutical. Its work centres on peptides, Cyclomimetics, drug development and antibodies.
R A Inc has approximately 1 employees.
R A Inc has completed 4 funding rounds, raising a total of $226.93M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to R A Inc include IXALTIS SA, FogPharma, Xeris Pharmaceuticals, Inc., BlossomHill Therapeutics, Inc., Blueberry Therapeutics Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
R A Inc and IXALTIS SA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for R A Inc, https://bouncewatch.com/company/ra-pharmaceuticals, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes